NEUROINMUNOLOGÍA
Instituto de Biomedicina y Biotecnología de Cantabria
Santander, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biomedicina y Biotecnología de Cantabria (3)
2018
-
Selective up-regulation of cannabinoid CB1 receptor coupling to Go-proteins in suicide victims with mood disorders
Biochemical Pharmacology, Vol. 157, pp. 258-265
2010
-
Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine1A receptor-dependent mechanisms
Molecular Pharmacology, Vol. 77, Núm. 3, pp. 424-434
2007
-
CB1 knockout mice display impaired functionality of 5-HT 1A and 5-HT2A/C receptors
Journal of Neurochemistry, Vol. 103, Núm. 5, pp. 2111-2120